Domain Therapeutics, a clinical-stage biopharmaceutical company developing highly differentiated therapeutic strategies targeting G protein-coupled receptors (GPCRs), has appointed Jean-Marie Cuillerot, M.D., as Chief Medical Officer (CMO). Experience Based in Boston, Cuillerot brings extensive pharmaceutical and biotech experience, with a proven track record in leading successful clinical development programs and regulatory strategy. Earlier in his career, he served as the medical lead at...